Castle Biosciences to Release Second Quarter 2026 Financial Results and Host Webcast on Thursday, July 30, 2026

Rhea-AI Summary

Castle Biosciences (Nasdaq:CSTL) will release its second quarter 2026 financial results after the market close on Thursday, July 30, 2026. Company management will host a webcast at 4:30 p.m. Eastern time to discuss the results, followed by a Q&A session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

What This Means

Castle Biosciences set its 2Q26 earnings release for July 30, 2026, with a webcast at 4:30 p.m. ET. ...

Analysis

Castle Biosciences set its 2Q26 earnings release for July 30, 2026, with a webcast at 4:30 p.m. ET. One prior earnings-date notice saw a typical move near 1.03%. Investors may watch for any shifts in fundamentals or outlook commentary.

Key Figures

Quarter end date: June 30, 2026 Earnings release date: July 30, 2026 Webcast time: 4:30 p.m. Eastern time +1 more

4 metrics

Quarter end date June 30, 2026 Second quarter 2026 reporting period

Earnings release date July 30, 2026 2Q 2026 results after market close

Webcast time 4:30 p.m. Eastern time 2Q 2026 results webcast on July 30, 2026

Webcast early access 10 minutes Recommended time to log in before webcast start

Previous Earnings date Reports

1 past event · Latest: Apr 15 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 15	Earnings date notice	Neutral	+1.0%	Announced Q1 2026 earnings release date and post-close webcast timing.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Prior earnings-date scheduling news prompted only a modest positive move, suggesting limited directional signal from such notices alone.

Historical Comparison

+1.0% avg move · Over the past six months, 1 prior earnings-date notice produced a typical move of about 1.03%. This ...

earnings date

+1.0%

Average Historical Move earnings date

Over the past six months, 1 prior earnings-date notice produced a typical move of about 1.03%. This new scheduling update is similar in nature, so its informational weight broadly matches that earlier event.

Regulatory & Risk Context

Short Interest: 5.11%

Short Interest

5.11% of float

0% 15% 30%+

low as of 2026-06-15 Days to cover: 5.23

Reported short interest reflects relatively low bearish positioning, implying more limited short-squeeze potential and generally moderate volatility from covering pressure alone.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FRIENDSWOOD, Texas, July 9, 2026 /PRNewswire/ -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the second quarter ended June 30, 2026, after the close of market on Thursday, July 30, 2026.

Company management will host a webcast to discuss its financial results at 4:30 p.m. Eastern time on the same day.

Webcast Details
The live webcast can be accessed here: https://event.choruscall.com/mediaframe/webcast.html?webcastid=gbu0MZxe, or via the webcast link on the Investor Relations page of the Company's website: https://ir.castlebiosciences.com/. Please access the webcast at least 10 minutes before the start time. A replay of the webcast will be available following its conclusion.

There will be a brief Question and Answer session following management commentary.

About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. With a primary focus in dermatologic and gastroenterological disease, we develop personalized, clinically actionable solutions that help improve disease management and patient outcomes.

We put people first—empowering patients and clinicians and informing care decisions through rigorous science and advanced molecular tests that support more confident treatment planning. To learn more, visit www.CastleBiosciences.com and connect with us on LinkedIn, Instagram, Facebook and X. 

DecisionDx-Melanoma, DecisionDx-CMSeq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, AdvanceAD-Tx, TissueCypher, Esopredict, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.

Investor Contact:
Camilla Zuckero
czuckero@castlebiosciences.com

Media Contact:
Allison Marshall
amarshall@castlebiosciences.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/castle-biosciences-to-release-second-quarter-2026-financial-results-and-host-webcast-on-thursday-july-30-2026-302821112.html

SOURCE Castle Biosciences, Inc.

FAQ

When will Castle Biosciences (CSTL) report its Q2 2026 financial results?

Castle Biosciences will report its Q2 2026 financial results on Thursday, July 30, 2026, after the market close. According to the company, management will discuss these results on a webcast later that afternoon.

What time is the Castle Biosciences (CSTL) Q2 2026 earnings webcast on July 30, 2026?

The Castle Biosciences Q2 2026 earnings webcast is scheduled for 4:30 p.m. Eastern time on July 30, 2026. According to the company, investors should log in at least 10 minutes before the start.

How can investors access the Castle Biosciences (CSTL) Q2 2026 earnings webcast?

Investors can access the Castle Biosciences Q2 2026 webcast via a provided webcast link or through the Investor Relations page on the company’s website. According to the company, the event will be available as a live stream.

Will a replay of the Castle Biosciences (CSTL) Q2 2026 earnings webcast be available?

A replay of the Castle Biosciences Q2 2026 earnings webcast will be available after the live event concludes. According to the company, investors can access the replay through the same webcast or Investor Relations webpage.

Will there be a Q&A session during the Castle Biosciences (CSTL) Q2 2026 webcast?

Yes, Castle Biosciences plans a brief Q&A session following management’s prepared remarks on the Q2 2026 webcast. According to the company, this allows participants to ask questions after the financial discussion.